Globus Medical, Inc. (GMED)

About Globus Medical, Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

As of November 3, 2026, Globus Medical, Inc. (GMED) stock rose to $80.16, up 0.88% (+$0.70) versus the previous close. On the day, shares have traded between $78.61 and $80.20. That puts GMED around the middle of its 52-week range of $60.26 to $101.40. Globus Medical, Inc. operates in the surgical & medical instruments & apparatus space and carries a market capitalization of roughly $10.48 billion, with about 272.7K shares changing hands.

Latest GMED news

• Is Intuitive Surgical Stock Worth More Than Its Competitors?trefis.com· Nov 3, 8:39 AM ET
• Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?Yahoo Finance· Nov 3, 8:15 AM ET
• BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View RaisedYahoo Finance· Nov 2, 12:08 PM ET
• BD Launches Liverty TIPS Stent Graft to Expand U.S. TreatmentYahoo Finance· Nov 2, 12:07 PM ET
• SOLV's Q3 Earnings: Can Growth Momentum Offset ERP-Related Headwinds?Yahoo Finance· Nov 2, 10:49 AM ET
• GMED vs. AXGN: Which Stock Should Value Investors Buy Now?Yahoo Finance· Nov 2, 10:40 AM ET
• Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a BetYahoo Finance· Nov 2, 8:55 AM ET
• Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?Yahoo Finance· Nov 2, 6:42 AM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want GMED headlines, alerts and AI research in one place? Create a free account →

• $GMED Lmao, the child r*pist @BrawlStreet cant even defend himself from being a moral scurge. Blocking truth is his only option. Typical pedo.

  @PedoInChief· Oct 14, 6:13 PM ET

• $NMTC We have shared individual patient stories and clinical experiences across the NeuroOne platform over time. Together, they also help tell a broader story about execution. At Mayo Clinic Florida, physicians reported experience across 25 patients with drug-resistant focal e…

  @NeuroOne_IR· Oct 2, 10:14 AM ET

• What does institutional validation look like in practice? Across NeuroOne’s platform, we are seeing that validation take different forms — from leading institutions selecting our StereoCED™ drug delivery technology for research programs, to published clinical experience and pa…

  @NeuroOne_IR· Sep 30, 10:31 AM ET

• $NMTC NeuroOne technologies have been selected by leading institutions across multiple areas of our platform. Mayo Clinic and the University of Minnesota, for example, have selected our StereoCED™ drug delivery technology for research programs evaluating new approaches in pedi…

  @NeuroOne_IR· Sep 28, 12:11 PM ET

• $GMED Globus Medical reported 6% overall revenue growth in the second quarter of 2026. Its expanding surgical platform adds intrigue, but competition still matters. https://biotechhealthx.com/biotech-news/globus-medical-gmed-a-6-growth-quarter-and-a-robotics-wild-card/

  @BioTechHealthX· Sep 26, 9:07 AM ET

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →